In Conversation

"Considering we are at the verge of Brexit, Denmark—as the rest of the EU—wants to put in place the most ambitious trade agreement ever made with…

"The Swiss government realised early on that Brexit would not only have an impact on the UK and the EU, but also on all third countries…

"We have a place on the global [biotech] podium and would like to go further"

"I believe we were very successful in integrating the people, processes and resources that have  joined the Mylan family"

We have a broad portfolio, from the very first vaccine that newborns receive to treatments for long term conditions such as diabetes and cardiovascular disease all…

"I really believe in the LSIS. I think it is something the UK is capable of delivering and something that should be a clear priority for…

"There is absolutely no doubt that the NHS will have to adapt to an evolving landscape if it is to continue to deliver world-class healthcare"

"We recognize that there is an enormous amount to do in arthritis, but also recognize that we cannot do it on our own. As a result,…

"J&J therefore remains the largest single foreign investor in life sciences in the UK"

"We need an immigration policy that will allow for the free movement of scientists. However, considering scientists often come with their families it is important that…

Most likely, the UK is the best environment for putting forward trials that are properly regulated. Initially that tipped a lot of venture capital into the…

"Our ambition is to be positioned right at the sharp end of scientific progress and to successfully translate that into meaningful medicines in areas of high…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here